Papers

1

Total Citations

15

H-Index

1

About

Yara Marghani is a pioneering researcher at the intersection of tissue engineering and hematological oncology, whose work centers on developing advanced three-dimensional disease models to study acute myeloid leukemia (AML). Her major contribution lies in the creation of a robotic multicellular bioprinting system that fabricates a bone marrow niche-like AML model, enabling unprecedented replication of the tumor microenvironment. This automated and controlled process, detailed in her 2023 paper (15 citations), addresses a critical gap in preclinical research by providing a robust platform to investigate drug resistance and disease relapse mechanisms. By mimicking the complex cellular architecture of the bone marrow, Marghani’s model offers a transformative tool for identifying novel therapeutic targets and testing treatments in a physiologically relevant context. Her work has been recognized for its innovation in bioprinting technology and its potential to reduce reliance on animal models. With growing citation impact, Marghani is establishing herself as a leader in cancer bioengineering, bridging engineering precision with clinical relevance to improve outcomes for AML patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Fabrication of a three-dimensional bone marrow niche-like acute myeloid Leukemia disease model by an automated and controlled process using a robotic multicellular bioprinting system
15 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 20
🏛 Institutions: King Abdullah University of Science and Technology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago